Gastrin-releasing peptide blockade as a broad-spectrum anti-inflammatory therapy for asthma.
Gastrin-releasing peptide (GRP) is synthesized by pulmonary neuroendocrine cells in inflammatory lung diseases, such as bronchopulmonary dysplasia (BPD). Many BPD infants develop asthma, a serious disorder of intermittent airway obstruction. Despite extensive research, early mechanisms of asthma remain controversial. The incidence of asthma is growing, now affecting >300 million people worldwide. To test the hypothesis that GRP mediates asthma, we used two murine models: ozone exposure for air pollution-induced airway hyperreactivity (AHR), and ovalbumin (OVA)-induced allergic airway disease. BALB/c mice were given small molecule GRP blocking agent 77427, or GRP blocking antibody 2A11, before exposure to ozone or OVA challenge. In both models, GRP blockade abrogated AHR and bronchoalveolar lavage (BAL) macrophages and granulocytes, and decreased BAL cytokines implicated in asthma, including those typically derived from Th1 (e.g., IL-2, TNFα), Th2 (e.g., IL-5, IL-13), Th17 (IL-17), macrophages (e.g., MCP-1, IL-1), and neutrophils (KC = IL-8). Dexamethasone generally had smaller effects on all parameters. Macrophages, T cells, and neutrophils express GRP receptor (GRPR). GRP blockade diminished serine phosphorylation of GRPR with ozone or OVA. Thus, GRP mediates AHR and airway inflammation in mice, suggesting that GRP blockade is promising as a broad-spectrum therapeutic approach to treat and/or prevent asthma in humans.
Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA. shutang.zhou@duke.edu
Shutang
S
Zhou
Erin N
EN
Potts
Frank
F
Cuttitta
W Michael
WM
Foster
Mary E
ME
Sunday
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001992:Bronchoalveolar Lavage Fluid; D005260:Female; D019886:Gastrin-Releasing Peptide / Q000037:antagonists & inhibitors*; D007150:Immunohistochemistry; D051379:Mice; D008807:Mice, Inbred BALB C
D000893:Anti-Inflammatory Agents; D019886:Gastrin-Releasing Peptide
Respir Med. 2006 Aug;100(8):1307-17
16412623
J Allergy Clin Immunol. 2002 May;109(5 Suppl):S482-9
11994720
Am J Respir Cell Mol Biol. 2009 Jul;41(1):107-13
19059883
J Clin Invest. 2003 Aug;112(4):495-7
12925688
Am J Respir Crit Care Med. 2003 Sep 1;168(5):601-11
12807697
J Pharm Pharmacol. 1973 Nov;25(11):872-5
4149649
Cancer Res. 1994 Mar 15;54(6):1517-28
8137258
Allergy. 2004 Nov;59(11):1139-52
15461593
Lab Invest. 2006 May;86(5):425-44
16568108
J Allergy Clin Immunol. 2005 Apr;115(4 Suppl):S526-31
15806035
Ann Oncol. 1997 May;8(5):457-61
9233525
J Natl Cancer Inst. 2000 Jan 5;92(1):24-33
10620630
Proc Natl Acad Sci U S A. 1995 May 9;92(10):4357-61
7753811
Am J Respir Crit Care Med. 2006 Jul 1;174(1):75-83
16574933
Anat Rec. 1993 May;236(1):169-71
8507003
Mol Pharmacol. 2003 Oct;64(4):890-904
14500746
Clin Cancer Res. 1999 Nov;5(11):3385-93
10589749
Exp Lung Res. 1999 Apr-May;25(3):261-73
10352955
Philos Trans R Soc Lond B Biol Sci. 1990 Mar 12;327(1239):209-21
1969660
Peptides. 2000 Nov;21(11):1627-38
11090916
Immunology. 1991 Jun;73(2):205-11
1649124
J Immunol. 2010 Feb 15;184(4):1663-74
20130218
Am J Physiol Lung Cell Mol Physiol. 2003 Jul;285(1):L32-42
12626335
Am J Physiol. 1993 Jan;264(1 Pt 1):L80-6
8381599
J Immunol. 2010 Mar 1;184(5):2377-85
20118277
Regul Pept. 1994 Jan 13;49(3):185-93
8140272
Respiration. 1996;63(1):28-34
8833990
Am J Respir Crit Care Med. 2002 Apr 15;165(8):1093-7
11956050
Chest. 1997 Jul;112(1):256-61
9228385
Nat Immunol. 2010 Jul;11(7):577-84
20562844
Oncogene. 2005 Jun 9;24(25):4106-13
15750618
Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):714-7
1679982
Am J Epidemiol. 1998 Sep 1;148(5):460-6
9737558
Eur J Pharmacol. 2008 Dec 14;600(1-3):117-22
18926814
J Clin Invest. 1989 Sep;84(3):900-6
2474576
Arch Histol Cytol. 1999 Mar;62(1):1-16
10223738
Am J Respir Crit Care Med. 1998 Sep;158(3):985-90
9731035
Am J Respir Cell Mol Biol. 1994 Jul;11(1):66-74
8018339
J Biol Chem. 1991 Oct 5;266(28):18771-9
1655761
Am J Respir Crit Care Med. 2003 Jan 1;167(1):57-64
12502477
N Engl J Med. 1992 Oct 29;327(18):1285-8
1406819
Neuropeptides. 1991 Dec;20(4):217-23
1812404
Pediatr Pulmonol. 2005 Aug;40(2):157-65
15965897
J Immunol. 2007 Oct 1;179(7):4367-75
17878331
Am J Respir Cell Mol Biol. 2004 Jul;31(1):69-77
14975936
Am J Respir Cell Mol Biol. 1990 Sep;3(3):199-205
2390263
J Allergy Clin Immunol. 2003 Jan;111(1 Suppl):S5-S12; discussion S12-7
12532083
Am J Respir Crit Care Med. 2007 Nov 1;176(9):902-12
17585105
Eur Respir J. 1994 Jun;7(6):1161-71
7925887
Pediatr Int. 2000 Dec;42(6):603-7
11192514
Ann N Y Acad Sci. 2010 Aug;1203:133-7
20716295
Clin Exp Allergy. 2005 Jul;35(7):954-9
16008684
J Clin Invest. 1998 Aug 1;102(3):584-94
9691095
Nature. 1978 Jun 29;273(5665):769-70
351419
Ann Intern Med. 2010 Feb 16;152(4):232-7
20157138
Mol Pharmacol. 1996 Oct;50(4):716-27
8863815
Clin Sci (Lond). 2005 Jun;108(6):463-77
15896192